CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,204,354 | -54.9% | 142,714 | -50.0% | 0.00% | -50.0% |
| Q2 2023 | $9,313,108 | -32.9% | 285,503 | -27.7% | 0.01% | -40.0% |
| Q1 2023 | $13,888,050 | +40.0% | 394,659 | +82.3% | 0.01% | +25.0% |
| Q4 2022 | $9,921,267 | +27.8% | 216,527 | +35.2% | 0.01% | +33.3% |
| Q3 2022 | $7,761,000 | +12.2% | 160,188 | -9.0% | 0.01% | 0.0% |
| Q2 2022 | $6,919,000 | +96.5% | 176,080 | +84.0% | 0.01% | +200.0% |
| Q1 2022 | $3,522,000 | -55.5% | 95,680 | -44.9% | 0.00% | -50.0% |
| Q4 2021 | $7,915,000 | +95.3% | 173,659 | +53.1% | 0.00% | +100.0% |
| Q3 2021 | $4,053,000 | -15.3% | 113,410 | -53.1% | 0.00% | -33.3% |
| Q2 2021 | $4,786,000 | +10.2% | 241,835 | +29.5% | 0.00% | 0.0% |
| Q1 2021 | $4,344,000 | +840.3% | 186,746 | +739.5% | 0.00% | – |
| Q4 2020 | $462,000 | +141.9% | 22,244 | +151.9% | 0.00% | – |
| Q3 2020 | $191,000 | -83.6% | 8,829 | -82.2% | 0.00% | -100.0% |
| Q2 2020 | $1,168,000 | +138.4% | 49,543 | +19.1% | 0.00% | – |
| Q1 2020 | $490,000 | +5.6% | 41,602 | -4.9% | 0.00% | – |
| Q4 2019 | $464,000 | -59.8% | 43,735 | -56.9% | 0.00% | -100.0% |
| Q3 2019 | $1,155,000 | +29.2% | 101,485 | +27.7% | 0.00% | 0.0% |
| Q2 2019 | $894,000 | +241.2% | 79,492 | +145.5% | 0.00% | – |
| Q1 2019 | $262,000 | -68.6% | 32,378 | -75.5% | 0.00% | -100.0% |
| Q4 2018 | $834,000 | +169.9% | 131,994 | +321.3% | 0.00% | – |
| Q3 2018 | $309,000 | +18.4% | 31,330 | -0.3% | 0.00% | – |
| Q2 2018 | $261,000 | -95.3% | 31,421 | -95.9% | 0.00% | -100.0% |
| Q1 2018 | $5,560,000 | -16.7% | 772,321 | -5.7% | 0.01% | 0.0% |
| Q4 2017 | $6,675,000 | -41.6% | 819,028 | +3.8% | 0.01% | -44.4% |
| Q3 2017 | $11,437,000 | +18.1% | 788,707 | -1.5% | 0.01% | 0.0% |
| Q2 2017 | $9,686,000 | +3.4% | 800,471 | +9.9% | 0.01% | +12.5% |
| Q1 2017 | $9,363,000 | +2.8% | 728,660 | -2.8% | 0.01% | 0.0% |
| Q4 2016 | $9,110,000 | +40.2% | 749,759 | +5.9% | 0.01% | +33.3% |
| Q3 2016 | $6,499,000 | -3.8% | 708,038 | -0.5% | 0.01% | -14.3% |
| Q2 2016 | $6,755,000 | +28.5% | 711,819 | -4.5% | 0.01% | +16.7% |
| Q1 2016 | $5,255,000 | -30.5% | 745,400 | +3.2% | 0.01% | -25.0% |
| Q4 2015 | $7,558,000 | +79.5% | 722,576 | +14.8% | 0.01% | +100.0% |
| Q3 2015 | $4,210,000 | +6183.6% | 629,257 | +6218.5% | 0.00% | – |
| Q2 2015 | $67,000 | +191.3% | 9,959 | +192.7% | 0.00% | – |
| Q1 2015 | $23,000 | -68.1% | 3,403 | -62.0% | 0.00% | – |
| Q4 2014 | $72,000 | +350.0% | 8,946 | +101.4% | 0.00% | – |
| Q3 2014 | $16,000 | +166.7% | 4,441 | +264.0% | 0.00% | – |
| Q2 2014 | $6,000 | -91.4% | 1,220 | -83.4% | 0.00% | – |
| Q1 2014 | $70,000 | +11.1% | 7,360 | -24.8% | 0.00% | – |
| Q4 2013 | $63,000 | +215.0% | 9,791 | +278.9% | 0.00% | – |
| Q3 2013 | $20,000 | – | 2,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |